EX-10.7
from 10-K
13 pages
Executive Employment Agreement This Executive Employment Agreement (The “Agreement”), Made Between Prelude Therapeutics Incorporated, a Delaware Corporation (The “Company”), and Bryant Lim (“Executive” And, Collectively With the Company, the “Parties”), Is Entered Into as of January 30, 2023. Whereas, the Company Desires to Employ Executive as the Company’s Chief Legal Counsel and Corporate Secretary. Now, Therefore, in Consideration of the Mutual Promises and Covenants Contained Herein and for Other Good and Valuable Consideration, the Receipt and Sufficiency of Which Is Hereby Acknowledged, the Parties Hereto Agree as Follows: 1. Employment by the Company. 1.1 Employment. This Agreement Shall Govern the Terms of Executive’s Employment With the Company, Which Shall Commence as of February 27, 2023 or Such Other Date as Mutually Determined by Executive and the Company (Such Date, the “Start Date”). 1.2
12/34/56